Diagnosis & Disease Information

Postmenopausal HRT Improves Sexual Function

Twelve months of daily oral hormonal replacement therapy with estradiol plus dihydrogesterone (HRT), dehydroepiandrosterone (DHEA), or tibolone improves sexual function and frequency in early postmenopausal women.

FDA warns of unintentional exposure to estrogen with Evamist

FDA warns of unintentional exposure to estrogen with Evamist

The FDA has notified healthcare professionals and patients that it is reviewing reports of adverse effects from Evamist (estradiol transdermal spray, from Ther-Rx) in children who may have been unintentionally exposed to the drug through skin contact with women using this product.